Sodium Glucose Transporter-2 (SGLT2) Inhibition to Prevent Cardiotoxicity?
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
Release Date: 07/29/2022
Fatty Liver, Fiercer Metastases, Future Targets 🧬
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🧬 New Nature study: fatty liver may do more than coexist with colorectal cancer liver metastases — it may shape their biology. Steatotic livers were linked to more aggressive “replacement” metastases, driven by fatty acid oxidation, MYC stabilization, proline synthesis, and collagen remodeling. The practical pearl: liver-fat content may become a biomarker for prognosis and trial selection, especially for MYC-targeted therapy. Metabolism is not background noise — it may be the soil that scripts metastatic fate. 🎯
info_outline
🩸 The Dementia Signal in Blood: GDF15 Points to Vascular Risk
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🧠 New Science Advances study: plasma growth/differentiation factor-15 (GDF15) measured in midlife and late life predicted long-term dementia risk, with the strongest signal for vascular dementia. The study links GDF15 to cerebral small vessel disease, neurodegeneration, phosphorylated tau, and neuroimmune activation—suggesting this blood biomarker may be more than a bystander. 🩸🔬 Key clinical pearl: dementia prevention may need to look beyond amyloid and focus earlier on vascular–immune biology. #Dementia #GDF15 #Neuroinflammation #VascularDementia #MedicalPodcasts
info_outline
🇺🇸 When Physicians Signed History ✍️
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🩺 In 1776, physicians were not just healers—they were signers, soldiers, governors, judges, and architects of a new republic. This NEJM Perspective reminds us that 5 Declaration signers were doctors, and asks a timely question: as health policy now shapes vaccines, research, insurance, and public trust, have physicians become too distant from national leadership? 🇺🇸 From bedside to body politic, the call for civic engagement still echoes. #MedicalHistory #PhysicianLeadership #HealthPolicy #NEJM #MedicalPodcasts
info_outline
Antiplatelets After ASCVD: Less Autopilot, More Judgment 🧭
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🩸 Antiplatelet therapy is no longer “aspirin for all” or “DAPT by habit.” The 2026 ACC Scientific Statement reframes care around precision: ischemic risk, bleeding risk, PCI/ACS context, PAD or stroke phenotype, surgery, anticoagulation, and adherence. The modern message: choose the right agent, right intensity, and right duration—then reassess. Platelets may be small, but the decisions are not. ⚖️🔬 Source: 2026 ACC Scientific Statement on antiplatelet therapy.
info_outline
HF 2026: Stage It, Source It, Follow It 🔍
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
❤️ New JACC statement, big clinical reset: the 2026 Second Universal Definition of Heart Failure moves us beyond rigid EF cutoffs toward a more useful bedside framework—define the syndrome, identify the stage, seek the cause, respect geography and social context, and follow the trajectory. The key message: improved EF is not “cured HF,” and pre-HF is a prevention window hiding in plain sight. For clinicians: less “What’s the EF?” and more “What’s the cause, stage, trajectory, and context?” 🫀🌍 #HeartFailure #Cardiology #JACC #MedicalPodcasts
info_outline
Less Guesswork, More Guardrails in ACC 2026 DOAC Playbook
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🩸 New JACC/ACC 2026 Scientific Statement spotlight: DOACs are now central to stroke and venous thromboembolism prevention—but not “one size fits all.” The practical message: choose the right agent, dose correctly, avoid DOACs in mechanical valves and rheumatic mitral stenosis, reassess renal/liver function, bleeding risk, drug interactions, adherence, and cost. In anticoagulation, the prescription is only the opening move; follow-up is where safety lives. ⚖️💊 #Cardiology #DOACs #AFib #VTE #MedicalPodcasts
info_outline
Great Doctors Series: Asclepiades of Prusa, The Doctor Who Made Healing Humane 🤝🩺
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
⚕️ Long before “holistic medicine” became fashionable, Asclepiades of Prusa was already practicing it in Rome. He challenged humoral doctrine, proposed that illness arose from disrupted motion of atoms through bodily pores, and treated patients with diet, exercise, massage, bathing, music, and humane attention rather than harsh dogma alone. His motto was memorable: cito, tuto, jucunde — swiftly, safely, and sweetly. 🍷🛁🎵 What stands out most is not only his theory, but his temperament: kind, patient-centered, and notably humane toward those with mental illness. A reminder...
info_outline
When Statins Meet Muscle: Mechanisms to Risk Prediction 🔬📊💪
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
💊 Statins save lives—but muscle concerns still derail uptake and adherence. Two timely papers sharpen the story: Science Advances unpacks a biologic mechanism linking statins to reduced protein prenylation, YAP, NLRP3 activation, and myopathy; The Lancet Digital Health offers a validated clinical prediction model for serious muscle disorders in statin-eligible patients. The message: most patients remain at low absolute risk, but better biology + better prediction can make statin conversations calmer, clearer, and more personalized. 💪📊🫀 #Cardiology #Statins #MedicalPodcasts...
info_outline
🫁 Lung, Gut, Uterus: Where Biological Aging Meets Early Cancer
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🧬 Why are early-onset cancers rising in newer generations? A Nature Medicine study of 154,169 UK Biobank participants found that biological aging increased across birth cohorts and was linked to higher early-onset solid cancer risk: HR 1.08 per standard deviation age-gap increase, driven by lung, gastrointestinal, and uterine cancers. Proteomics added a clue: immune aging tracked with lung cancer, adipose aging with colorectal cancer. ⏳ The clock may be ticking earlier than we thought. #CancerPrevention #PrecisionMedicine #BiologicalAging #MedicalPodcasts
info_outline
Weight Loss Without Lean-Mass Loss? The Methionine Longevity Diet 🌿🔥
Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!
🧬 Can a diet improve healthspan without worsening frailty? In this Cell Metabolism study, a low-protein longevity diet supplemented with moderate methionine reduced fat mass and frailty, preserved lean mass, improved insulin sensitivity, and increased GH, GLP-1, and FGF21 in aged mice. Western and ketogenic diets moved the needle the wrong way: more fat, more frailty, worse metabolic signals. The clinical message: optimize protein quality and methionine balance—not extremes. 🌱⚖️ #Longevity #Healthspan #Frailty #Nutrition #MedicalPodcasts
info_outlineSodium Glucose Transporter-2 (SGLT2) Inhibition to Prevent Chemotherapy Induced Cardiotoxicity?
Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians
References
Martinez CA, Scafoglio C. Heterogeneity of Glucose Transport in Lung Cancer. Biomolecules. 2020
Fang JC. Heart-Failure Therapy - New Drugs but Old Habits?. N Engl J Med. 2019